| O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma (NCT00005066) | University of Chicago | 2000-06-01 |
| Chemotherapy in Treating Patients With Sarcoma of the Uterus (NCT00005643) | Gynecologic Oncology Group | 2000-05-01 |
| Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer (NCT00005655) | National Cancer Institute (NCI) | 2000-04-28 |
| Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy (NCT00035620) | Amgen | 2000-04-01 |
| Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract (NCT00582647) | Memorial Sloan Kettering Cancer Center | 2000-03-01 |
| Specimen and Data Study for Ovarian Cancer Early Detection and Prevention (NCT00005095) | Northwestern University | 2000-03-01 |
| Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors (NCT00014456) | Dartmouth-Hitchcock Medical Center | 2000-03-01 |
| SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma (NCT00005042) | AIDS Malignancy Consortium | 2000-01-01 |
| Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma (NCT00005625) | Memorial Sloan Kettering Cancer Center | 1999-12-01 |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma (NCT00004261) | University Health Network, Toronto | 1999-12-01 |
| Trastuzumab in Treating Patients With Recurrent Osteosarcoma (NCT00005033) | Memorial Sloan Kettering Cancer Center | 1999-12-01 |
| MRI Sarcoma Non Invasive Thermometry (NCT00093509) | Mark Dewhirst | 1999-11-01 |
| Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma (NCT00005628) | Memorial Sloan Kettering Cancer Center | 1999-11-01 |
| Rosiglitazone in Treating Patients With Liposarcoma (NCT00004180) | Dana-Farber Cancer Institute | 1999-10-01 |
| Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma (NCT00003937) | Children's Oncology Group | 1999-09-01 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma (NCT00003955) | Children's Oncology Group | 1999-09-01 |
| Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery (NCT00004250) | Memorial Sloan Kettering Cancer Center | 1999-08-01 |
| Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma (NCT00004066) | Memorial Sloan Kettering Cancer Center | 1999-06-01 |
| Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas (NCT00005874) | Astex Pharmaceuticals, Inc. | 1999-06-01 |
| Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas (NCT00003745) | National Cancer Institute (NCI) | 1999-05-01 |
| Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma (NCT00003778) | National Cancer Institute (NCI) | 1999-04-01 |
| Combination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma (NCT00003776) | Memorial Sloan Kettering Cancer Center | 1998-12-01 |
| Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma (NCT00003793) | Children's Oncology Group | 1998-12-01 |
| Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors (NCT00003926) | Masonic Cancer Center, University of Minnesota | 1998-11-01 |
| Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors (NCT00025441) | Societe Internationale d'Oncologie Pediatrique | 1998-11-01 |
| Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma (NCT00003667) | Memorial Sloan Kettering Cancer Center | 1998-09-01 |
| Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma (NCT00003718) | Herbert Irving Comprehensive Cancer Center | 1998-09-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer (NCT00004105) | NYU Langone Health | 1998-09-01 |
| Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus (NCT00003316) | Gynecologic Oncology Group | 1998-08-01 |
| Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation (NCT00003887) | Fred Hutchinson Cancer Center | 1998-08-01 |
| SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma (NCT00003720) | Pfizer | 1998-07-01 |
| Antiviral Therapy in Treating Patients With Slowly Progressing HIV-Related Kaposi's Sarcoma (NCT00003419) | Centro di Riferimento Oncologico - Aviano | 1998-06-01 |
| Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus (NCT00003156) | Gynecologic Oncology Group | 1998-06-01 |
| Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer (NCT00003408) | Cancer Treatment Centers of America | 1998-04-01 |
| Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma (NCT00004109) | M.D. Anderson Cancer Center | 1998-03-01 |
| Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors (NCT00003141) | Children's Oncology Group | 1998-03-01 |
| Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma (NCT00003081) | Fred Hutchinson Cancer Center | 1998-03-01 |
| Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma (NCT00003212) | European Organisation for Research and Treatment of Cancer - EORTC | 1998-01-01 |
| Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma (NCT00003008) | Eastern Cooperative Oncology Group | 1997-12-15 |
| Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect (NCT00003425) | University of Kentucky | 1997-12-01 |
| Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus (NCT00003128) | Gynecologic Oncology Group | 1997-11-01 |
| Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor (NCT00003273) | NYU Langone Health | 1997-11-01 |
| Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus (NCT00003054) | Gynecologic Oncology Group | 1997-08-01 |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma (NCT00002995) | Children's Oncology Group | 1997-08-01 |
| Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus (NCT00002993) | Gynecologic Oncology Group | 1997-08-01 |
| Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma (NCT00003052) | European Organisation for Research and Treatment of Cancer - EORTC | 1997-07-01 |
| Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma (NCT00003719) | Herbert Irving Comprehensive Cancer Center | 1997-07-01 |
| Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma (NCT00004123) | M.D. Anderson Cancer Center | 1997-07-01 |
| Troglitazone in Treating Patients With Liposarcoma (NCT00003058) | Dana-Farber Cancer Institute | 1997-06-01 |
| Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity (NCT00001577) | National Cancer Institute (NCI) | 1997-06-01 |
| Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors (NCT00007813) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1997-05-31 |
| Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer (NCT00003022) | Memorial Sloan Kettering Cancer Center | 1997-04-01 |
| A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancy (NCT00001573) | National Cancer Institute (NCI) | 1997-03-01 |
| Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract (NCT00003334) | NYU Langone Health | 1997-03-01 |
| Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer (NCT00003023) | Memorial Sloan Kettering Cancer Center | 1997-03-01 |
| Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma (NCT00002791) | Radiation Therapy Oncology Group | 1997-02-01 |
| Spectroscopy With Surface Coils and Decoupling (NCT00581815) | Memorial Sloan Kettering Cancer Center | 1997-02-01 |
| Docetaxel in Treating Children With Recurrent Solid Tumors (NCT00002825) | National Cancer Institute (NCI) | 1997-01-01 |
| Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma (NCT00002985) | Roswell Park Cancer Institute | 1996-11-01 |
| Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma (NCT00002804) | Children's Oncology Group | 1996-09-01 |
| Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma (NCT00002974) | University of Wisconsin, Madison | 1996-07-01 |
| Altretamine and Etoposide in Treating Patients With HIV-Related Cancer (NCT00002936) | Roswell Park Cancer Institute | 1996-07-01 |
| Cryosurgery in Treating Patients With Soft Tissue Sarcoma (NCT00002863) | University of Southern California | 1996-06-01 |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma (NCT00002764) | European Organisation for Research and Treatment of Cancer - EORTC | 1996-04-01 |
| Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma (NCT00019123) | National Cancer Institute (NCI) | 1996-04-01 |
| Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma (NCT00002738) | Memorial Sloan Kettering Cancer Center | 1996-01-01 |
| Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor (NCT00002643) | National Cancer Institute (NCI) | 1995-04-01 |
| Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma (NCT00002641) | European Organisation for Research and Treatment of Cancer - EORTC | 1995-02-01 |
| Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma (NCT00002898) | Societe Internationale d'Oncologie Pediatrique | 1995-01-01 |
| Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma (NCT00002601) | City of Hope Medical Center | 1994-09-01 |
| Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors (NCT00002608) | Ottawa Regional Cancer Centre | 1994-05-01 |
| Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus (NCT00002546) | Gynecologic Oncology Group | 1993-12-01 |
| Retinoblastoma Biomarker Study (NCT00342797) | National Cancer Institute (NCI) | 1993-11-17 |
| Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma (NCT00002539) | European Organisation for Research and Treatment of Cancer - EORTC | 1993-08-01 |
| Chemotherapy in Treating Patients With Advanced Sarcoma (NCT00002526) | Swiss Cancer Institute | 1993-01-01 |
| Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer (NCT00002515) | Memorial Sloan Kettering Cancer Center | 1992-10-01 |
| Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma (NCT00002516) | University Hospital Muenster | 1992-07-01 |
| Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer (NCT00002485) | Children's Oncology Group | 1992-02-01 |
| Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma (NCT00002492) | University of Miami | 1991-11-01 |
| Combination Chemotherapy in Treating Patients With Sarcoma (NCT00662233) | Mayo Clinic | 1991-10-01 |
| Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma (NCT00645632) | Mayo Clinic | 1990-11-01 |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer (NCT00002466) | Memorial Sloan Kettering Cancer Center | 1990-05-01 |
| Patterns of Care and Outcomes in METAstatic Soft Tissue SARComa (NCT03977818) | Institut Bergonié | 1990-01-01 |
| Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus (NCT00002459) | European Organisation for Research and Treatment of Cancer - EORTC | 1988-04-01 |
| A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors (NCT00001209) | National Cancer Institute (NCI) | 1986-10-01 |
| The Role of Multi-Modality Therapy for the Treatment of High-Grade Soft Tissue Sarcomas of the Extremities (NCT00001188) | National Cancer Institute (NCI) | 1983-12-01 |
| The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors (NCT00001189) | National Cancer Institute (NCI) | 1983-12-01 |
| Karyopharm Expanded Access Program for Selinexor (NCT07215832) | Karyopharm Therapeutics Inc | |
| Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer (NCT00093678) | Eastern Cooperative Oncology Group | |
| BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast (NCT04091295) | Aveni Foundation | |
| Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma (NCT00003801) | National Cancer Institute (NCI) | |
| Compassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy (NCT02570412) | CytRx | |
| Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval (NCT06751524) | Agenus Inc. | |
| A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment (NCT00210665) | Janssen Research & Development, LLC | |